Stay informed about EMBL news by subscribing to press releases.
For more information please contact the Press Officer:
Meyerhofstraße 1, Heidelberg, 69117, Germany
Tel: +49 6221 387-8443
Heidelberg, 22 March 2018 LifeTime - a visionary proposal for an EU Flagship Reliably predicting the onset and trajectory of a disease might seem like a distant dream. But a European consortium is aiming to achieve exactly this using a set of emerging technologies with the analysis of single cells at their core. Leading scientists - amongst whom several from EMBL - have now submitted the proposal for a FET Flagship called LifeTime.
Heidelberg, 19 March 2018 Molecular cuisine for gut bacteria Scientific recipes to successfully grow and study gut bacteria in the lab: that’s what EMBL scientists from the Bork, Patil, and Typas groups are publishing in Nature Microbiology on March 19. They report on the nutritional preferences and growth characteristics of 96 diverse gut bacterial strains. Their results will help scientists worldwide advance our understanding of the gut microbiome.
Heidelberg, 19 March 2018 Commonly used drugs affect our gut bacteria One in four drugs with human targets inhibit the growth of bacteria in the human gut. These drugs cause antibiotic-like side-effects and may promote antibiotic resistance, EMBL researchers from the Bork, Patil, Typas, and Zeller groups report in Nature on March 19.
Heidelberg, 15 March 2018 Potential new way to limit antibiotic resistance spreading One of the biggest current threats to global health is the rise of multi-drug resistant bacteria, caused by the spreading of antibiotic resistance amongst them. In an attempt to help fight this threat, EMBL researchers Anna Rubio-Cosials, Orsolya Barabas, and colleagues have unraveled the molecular basis of a major antibiotic resistance transfer mechanism. They also developed molecules and a proof-of-principle for blocking this transfer. Cell publishes their results on March 15.
Heidelberg, 14 March 2018 Chromatin usage in individual cells reveals developmental trajectories Both cell type and developmental stage can be deduced from chromatin accessibility measurements in thousands of single cells, researchers from the Furlong group at EMBL and the University of Washington show. They used this approach to uncover how cells in developing embryos regulate their identity as they decide what kind of cell to become. Nature publishes the results on March 14.
Heidelberg, 7 March 2018 Accelerating antibody discovery New EMBL spinoff company Velabs Therapeutics strives to speed up the discovery of new and better therapeutic antibodies, by making a new microfluidics platform - developed by EMBL group leader Christoph Merten - available to the global antibody research community.
Heidelberg, 22 February 2018 Synchronised waves control embryonic patterning During an embryo’s journey from a single cell to a complex organism, countless patterning processes make sure that the right cells develop in exactly the right location and at the right time. Cells activate specific genes in a rhythmic manner during this early development, resulting in waves of activation sweeping through the embryo. Scientists from the Aulehla and Merten labs at EMBL now show that the rhythm between two specific sets of waves – controlled by the Wnt and Notch pathways – enables the formation of new segments. The journal Cell published their results on February 22.
Heidelberg, 21 December 2017 Mapping molecules on people, fields and ATM machines Every day, every inch of skin on your body comes into contact with thousands of molecules – from skin cream, sweat, even from the microbes that call your skin home. Now scientists can create interactive 3D maps that show where each molecule lingers on our bodies, but also on other objects, thanks to a new method that researchers at EMBL and University of California San Diego have made available in Nature Protocols.
Heidelberg, 31 August 2017 German state and federal governments agree on funding for a high-resolution microscopy centre in Heidelberg The German state and federal governments have agreed on funding for a high-resolution microscopy centre at EMBL in Heidelberg. The letter of intent was signed today during an official ceremony at EMBL's Heidelberg campus by representatives of the German government together with industry and foundation partners. The new centre for light and electron microscopy will be a unique service facility for the life sciences and unite cutting-edge equipment, experts and data analysis. It will be open to visiting scientists from all over the world as well as industry partners.
Heidelberg, 28 June 2017 EMBL Council selects next Director General At its 53rd meeting yesterday, EMBL Council selected Edith Heard as the organisation's fifth Director General. Heard's mandate is scheduled to begin 1 January 2019. She is currently Director of the Genetics and Developmental Biology Unit at Institut Curie and holds the chair of Epigenetics and Cellular Memory at the Collège de France. "Edith is an outstanding molecular biologist and scientific leader with a lot of international experience. Her clear scientific vision, her participatory leadership style, and her engagement at all levels of research, service and training make her a perfect choice,” said Patrick Cramer, Chair of EMBL Council.
Policy regarding use
Press and Picture Releases
EMBL press and picture releases including photographs, graphics, movies and videos are copyrighted by EMBL. They may be freely reprinted and distributed for non-commercial use via print, broadcast and electronic media, provided that proper attribution to authors, photographers and designers is made.